|
1
|
Carlomagno N, Santangelo ML, Amato B,
Calogero A, Saracco M, Cremone C, Miranda A, Dodaro C and Renda A:
Total colectomy for cancer: Analysis of factors linked to patients'
age. Int J Surg. 12 (Suppl 2):S135–S139. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Strand MS, Lockhart AC and Fields R:
Genetics of gastric cancer. Surg Clin North Am. 97:345–370. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hamashima C: Current issues and future
perspectives of gastric cancer screening. World J Gastroenterol.
20:13767–13774. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baker NE: Transcription of the
segment-polarity gene wingless in the imaginal discs of drosophila,
and the phenotype of a pupal-lethal wg mutation. Development.
102:489–497. 1988.PubMed/NCBI
|
|
6
|
Croce JC and McClay DR: Evolution of the
Wnt pathways. Methods Mol Biol. 469:3–18. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rapp J, Jaromi L, Kvell K, Miskei G and
Pongracz JE: WNT signaling - lung cancer is no exception. Respir
Res. 18:1672017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Byun T, Karimi M, Marsh JL, Milovanovic T,
Lin F and Holcombe RF: Expression of secreted Wnt antagonists in
gastrointestinal tissues: Potential role in stem cell homeostasis.
J Clin Pathol. 58:515–519. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barker N, Huch M, Kujala P, van de
Wetering M, Snippert HJ, van Es JH, Sato T, Stange DE, Begthel H,
van den Born M, et al: Lgr5(+ve) stem cells drive self-renewal in
the stomach and build long-lived gastric units in vitro. Cell Stem
Cell. 6:25–36. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi
ST, Siu HC, Deng S, Chu KM, Law S, et al: Whole-genome sequencing
and comprehensive molecular profiling identify new driver mutations
in gastric cancer. Nat Genet. 46:573–582. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cristescu R, Lee J, Nebozhyn M, Kim KM,
Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al: Molecular
analysis of gastric cancer identifies subtypes associated with
distinct clinical outcomes. Nat Med. 21:449–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nagaoka T, Karasawa H, Turbyville T,
Rangel MC, Castro NP, Gonzales M, Baker A, Seno M, Lockett S, Greer
YE, et al: Cripto-1 enhances the canonical Wnt/β-catenin signaling
pathway by binding to LRP5 and LRP6 co-receptors. Cell Signal.
25:178–189. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Garinis GA, Spanakis NE, Menounos PG,
Manolis EN and Peros G: Transcriptional impairment of
beta-catenin/E-cadherin complex is not associated with beta-catenin
mutations in colorectal carcinomas. Br J Cancer. 88:206–209. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kikuchi A, Yamamoto H, Sato A and
Matsumoto S: New insights into the mechanism of Wnt signaling
pathway activation. Int Rev Cell Mol Biol. 291:21–71. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-mesenchymal transition in cancer: Parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Peng Z, Wang CX, Fang EH, Wang GB and Tong
Q: Role of epithelial-mesenchymal transition in gastric cancer
initiation and progression. World J Gastroenterol. 20:5403–5410.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yue H, Tang B, Zhao Y, Niu Y, Yin P, Yang
W, Zhang Z and Yu P: MIR-519d suppresses the gastric cancer
epithelial-mesenchymal transition via Twist1 and inhibits
Wnt/β-catenin signaling pathway. Am J Transl Res. 9:3654–3664.
2017.PubMed/NCBI
|
|
19
|
Cho ES, Kang HE, Kim NH and Yook JI:
Therapeutic implications of cancer epithelial-mesenchymal
transition (EMT). Arch Pharm Res. 42:14–24. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fuchs R, Schwach G, Stracke A,
Meier-Allard N, Absenger M, Ingolic E, Haas HS, Pfragner R and
Sadjak A: The anti-hypertensive drug prazosin induces apoptosis in
the medullary thyroid carcinoma cell line TT. Anticancer Res.
35:31–38. 2015.PubMed/NCBI
|
|
21
|
Lin OA, Karim ZA, Vemana HP, Espinosa EV
and Khasawneh FT: The antidepressant 5-HT2A receptor
antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced
platelet function. PLoS One. 9:e870262014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Speight TM and Avery GS:
Pizotifen(BC-105): A review of its pharmacological properties and
its therapeutic efficacy in vascular headaches. Drugs. 3:159–203.
1972. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ahmadi AA, Shadifar M, Ataee R,
Vaillancourt C, Ataee A, Oufkir T and Jafari-Sabet M: The serotonin
5-HT2A receptor antagonist ritanserin induces apoptosis
in human colorectal cancer and acts in synergy with curcumin. Int
Biol Biomed J. 1:56–65. 2015.
|
|
24
|
Liu J, Wu X, Mitchell B, Kintner C, Ding S
and Schultz PG: A small-molecule agonist of the Wnt signaling
pathway. Angew Chem Int Ed Engl. 44:1987–1990. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cheng YY, Yu J, Wong YP, Man EP, To KF,
Jin VX, Li J, Tao Q, Sung JJ, Chan FK and Leung WK: Frequent
epigenetic inactivation of secreted frizzled-related protein 2
(SFRP2) by promoter methylation in human gastric cancer. Br J
Cancer. 97:895–901. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hanaki H, Yamamoto H, Sakane H, Matsumoto
S, Ohdan H, Sato A and Kikuchi A: An anti-Wnt5a antibody suppresses
metastasis of gastric cancer cells in vivo by inhibiting
receptor-mediated endocytosis. Mol Cancer Ther. 11:298–307. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ataee R, Ajdary S, Zarrindast M, Rezayat M
and Hayatbakhsh MR: Anti-mitogenic and apoptotic effects of 5-HT1B
receptor antagonist on HT29 colorectal cancer cell line. J Cancer
Res Clin Oncol. 136:1461–1469. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Soll C, Riener MO, Oberkofler CE,
Hellerbrand C, Wild PJ, DeOliveira ML and Clavien PA: Expression of
serotonin receptors in human hepatocellular cancer. Clin Cancer
Res. 18:5902–5910. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vicentini LM, Cattaneo MG and Fesce R:
Evidence for receptor subtype cross-talk in the mitogenic action of
serotonin on human small-cell lung carcinoma cells. Eur J
Pharmacol. 318:497–504. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Soll C, Jang JH, Riener MO, Moritz W, Wild
PJ, Graf R and Clavien PA: Serotonin promotes tumor growth in human
hepatocellular cancer. Hepatology. 51:1244–1254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dizeyi N, Hedlund P, Bjartell A, Tinzl M,
Austild-Taskén K and Abrahamsson PA: Serotonin activates MAP kinase
and PI3K/Akt signaling pathways in prostate cancer cell lines. Urol
Oncol. 29:436–445. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Siddiqui EJ, Shabbir MA, Mikhailidis DP,
Mumtaz FH and Thompson CS: The effect of serotonin and serotonin
antagonists on bladder cancer cell proliferation. BJU Int.
97:634–639. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hirokawa Y, Yip KH, Tan CW and Burgess AW:
Colonic myofibroblast cell line stimulates colonoid formation. Am J
Physiol Gastrointest Liver Physiol. 306:G547–G556. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Byun MR, Hwang JH, Kim AR, Kim KM, Hwang
ES, Yaffe MB and Hong JH: Canonical Wnt signalling activates TAZ
through PP1A during osteogenic differentiation. Cell Death Differ.
21:854–863. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bu G, Lu W, Liu CC, Selander K, Yoneda T,
Hall C, Keller ET and Li Y: Breast cancer-derived Dickkopf1
inhibits osteoblast differentiation and osteoprotegerin expression:
Implication for breast cancer osteolytic bone metastases. Int J
Cancer. 123:1034–1042. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
He S, Lu Y, Liu X, Huang X, Keller ET,
Qian CN and Zhang J: Wnt3a: Functions and implications in cancer.
Chin J Cancer. 34:554–562. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pan KF, Liu WG, Zhang L, You WC and Lu YY:
Mutations in components of the Wnt signaling pathway in gastric
cancer. World J Gastroenterol. 14:1570–1574. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kahn M: Can we safely target the WNT
pathway? Nat Rev Drug Discov. 13:513–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mook RA Jr, Wang J, Ren XR, Chen M,
Spasojevic I, Barak LS, Lyerly HK and Chen W: Structure-activity
studies of Wnt/β-catenin inhibition in the niclosamide chemotype:
Identification of derivatives with improved drug exposure. Bioorg
Med Chem. 23:5829–5838. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Steinhart Z, Pavlovic Z, Chandrashekhar M,
Hart T, Wang X, Zhang X, Robitaille M, Brown KR, Jaksani S,
Overmeer R, et al: Corrigendum: Genome-wide CRISPR screens reveal a
Wnt-FZD5 signaling circuit as a druggable vulnerability of
RNF43-mutant pancreatic tumors. Nat Med. 23:13842017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim H, Yoo SB, Sun P, Jin Y, Jheon S, Lee
CT and Chung JH: Alteration of the E-cadherin/β-catenin complex is
an independent poor prognostic factor in lung adenocarcinoma.
Korean J Pathol. 47:44–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cheng XX, Wang ZC, Chen XY, Sun Y, Kong
QY, Liu J, Gao X, Guan HW and Li H: Frequent loss of membranous
E-cadherin in gastric cancers: A cross-talk with Wnt in determining
the fate of beta-catenin. Clin Exp Metastasis. 22:85–93. 2005.
View Article : Google Scholar : PubMed/NCBI
|
